Predictive value of clinical toxicities of chemotherapy with fluoropyrimidines and oxaliplatin in colorectal cancer by DPYD and GSTP1 gene polymorphisms.

Deng, Xunwei; Hou, Jingyuan; Deng, Qiaoting; Zhong, Zhixiong

Deng, Xunwei; Hou, Jingyuan; Deng, Qiaoting; Zhong, Zhixiong.

Afiliação

Deng X; Department of Research Experimental Center, Meizhou People's Hospital (Huangtang Hospital), Meizhou Hospital Affiliated to Sun Yat-Sen University, No. 63 Huangtang Road, Meijiang District, Meizhou, 514031, People's Republic of China.
Hou J; Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translational Research of Hakka Population, Meizhou, People's Republic of China.
Deng Q; Department of Research Experimental Center, Meizhou People's Hospital (Huangtang Hospital), Meizhou Hospital Affiliated to Sun Yat-Sen University, No. 63 Huangtang Road, Meijiang District, Meizhou, 514031, People's Republic of China.
Zhong Z; Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translational Research of Hakka Population, Meizhou, People's Republic of China.

World J Surg Oncol ; 18(1): 321, 2020 Dec 06.

Article em En | MEDLINE | ID: mdl-33280607

Assuntos

Neoplasias Colorretais; Di-Hidrouracila Desidrogenase (NADP); Antimetabólitos Antineoplásicos/uso terapêutico; Neoplasias Colorretais/tratamento farmacológico; Neoplasias Colorretais/genética; Di-Hidrouracila Desidrogenase (NADP)/genética; Fluoruracila; Genótipo; Glutationa S-Transferase pi/genética; Humanos; Oxaliplatina; Prognóstico

Palavras-chave

Chemotherapy toxicity; DPYD; GSTP1; Gene polymorphism; Hakka population

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Di-Hidrouracila Desidrogenase (NADP) Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google